Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Holding EXAS?
Track your performance easily
See the Price Targets and Ratings of:
EXAS Analyst Ratings
Strong Buy
19 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
EXAS Stock 12 Month Forecast
Average Price Target
$71.53
▲(20.42% Upside)
| Highest Price Target$86.00 | Average Price Target$71.53 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
12/13/24
TD Cowen
Assigned
12/11/24
Jefferies
Reiterated
12/11/24
Piper Sandler
Assigned
11/26/24
Bernstein
Reiterated
11/26/24
Stifel Nicolaus
Reiterated
11/26/24
BTIG
Reiterated
11/26/24
Wells Fargo
Reiterated
11/25/24
Leerink Partners
Assigned
11/25/24
Scotiabank
Assigned
11/07/24
Craig-Hallum
$65
Buy
9.43%
Upside
Assigned
11/06/24
Exact Sciences (EXAS) Receives a Buy from Craig-Hallum
Robert W. Baird
$70→$67
Buy
12.79%
Upside
Reiterated
11/06/24
Exact Sciences price target lowered to $67 from $70 at BairdExact Sciences price target lowered to $67 from $70 at Baird
Goldman Sachs
$75→$65
Buy
9.43%
Upside
Reiterated
11/06/24
Exact Sciences (EXAS) PT Lowered to $65 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on Exact Sciences (NASDAQ: EXAS) to $65.00 (from $75.00) while maintaining a Buy rating.
Evercore ISI
$80→$60
Buy
1.01%
Upside
Reiterated
11/06/24
Exact Sciences price target lowered to $60 from $80 at Evercore ISIExact Sciences price target lowered to $60 from $80 at Evercore ISI
Citi
$80→$75
Buy
26.26%
Upside
Reiterated
11/06/24
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (NYSE: HCA), Exact Sciences (NASDAQ: EXAS) and Crispr Therapeutics AG (NASDAQ: CRSP)
Best Analysts Covering Exact Sciences
Which Analyst Should I Follow If I Want to Buy EXAS and Sell After:
1 Month
xxx
Success Rate
23/35 ratings generated profit
Average Return
+8.05%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.71% of your transactions generating a profit, with an average return of +8.05% per trade.
3 Months
xxx
Success Rate
17/24 ratings generated profit
Average Return
+6.14%
assigned a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.83% of your transactions generating a profit, with an average return of +6.14% per trade.
1 Year
Success Rate
15/21 ratings generated profit
Average Return
+33.23%
reiterated a buy rating 3 months ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +33.23% per trade.
2 Years
xxx
Success Rate
24/35 ratings generated profit
Average Return
+134.52%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 68.57% of your transactions generating a profit, with an average return of +134.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
EXAS Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
12
6
1
3
3
Buy
10
22
27
42
31
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
28
28
45
34
Each month's total comprises the sum of three months' worth of ratings.
EXAS Financial Forecast
EXAS Stock Forecast FAQ
What is EXAS’s average 12-month price target, according to analysts?
Based on analyst ratings, Exact Sciences Corp.’s 12-month average price target is $71.53.
What is EXAS’s upside potential, based on the analysts’ average price target?
Exact Sciences Corp. has 20.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is EXAS a Buy, Sell or Hold?
Exact Sciences Corp. has a consensus rating of Strong Buy which is based on 19 buy ratings, 0 hold ratings and 0 sell ratings.
What is Exact Sciences Corp.’s price target?
The average price target for Exact Sciences Corp. is $71.53. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $86.00 ,the lowest forecast is $60.00. The average price target represents 20.42% Increase from the current price of $59.4.
The highest analyst price target is $86.00 ,the lowest forecast is $60.00. The average price target represents 20.42% Increase from the current price of $59.4.
What do analysts say about Exact Sciences Corp.?
Exact Sciences Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of EXAS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.